Clincosm LogoSign in Get a demo

Cluster Headache Treatment Survey

Sponsor
The University of Texas Health Science Center, Houston (Other)
Overall Status
Recruiting
CT.gov ID
NCT06011811
Collaborator
Clusterbusters, Inc. (Other)
5,000
Enrollment
1
Location
24
Anticipated Duration (Months)
208.5
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The objective of this study is to survey patients with cluster headache about treatment effectiveness and their views on treatments. Participants will complete one brief questionnaire online.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    5000 participants
    Observational Model:
    Cohort
    Time Perspective:
    Cross-Sectional
    Official Title:
    Cluster Headache Treatment Survey
    Actual Study Start Date :
    Jun 29, 2023
    Anticipated Primary Completion Date :
    Jun 28, 2025
    Anticipated Study Completion Date :
    Jun 28, 2025

    Arms and Interventions

    Arm Intervention/Treatment
    Patients with episodic or chronic cluster headache

    Patients with a diagnosis of episodic or chronic cluster headache, as diagnosed by a health care professional and to be confirmed by questions on the study survey.

    Outcome Measures

    Primary Outcome Measures

    1. Effectiveness of cluster headache treatment as assessed by a survey [at the time of survey completion, expected to be 6-12 months]

    Secondary Outcome Measures

    1. Opinions on new cluster headache treatment as assessed by a survey [at the time of survey completion, expected to be 6-12 months]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Patients with episodic or chronic cluster headache that has been diagnosed by a health care professional (no documentation is needed, participant must simply state that he or she has been diagnosed)
    Exclusion Criteria:

    • Unable to speak English (the survey is only in English)

    • Unable to use a computer to take the online survey

    • Unable to provide consent

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 The University of Texas Health Science Center at Houston Houston Texas United States 77030

    Sponsors and Collaborators

    • The University of Texas Health Science Center, Houston
    • Clusterbusters, Inc.

    Investigators

    • Principal Investigator: Mark J Burish, MD, PhD, The University of Texas Health Science Center, Houston

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    None provided.
    Responsible Party:
    Mark J Burish, Associate Professor, The University of Texas Health Science Center, Houston
    ClinicalTrials.gov Identifier:
    NCT06011811
    Other Study ID Numbers:
    • HSC-MS-23-0212
    First Posted:
    Aug 25, 2023
    Last Update Posted:
    Aug 25, 2023
    Last Verified:
    Aug 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:
    Cluster Headache
    Headache

    Study Results

    No Results Posted as of Aug 25, 2023